HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eun Yong Chung Selected Research

alpha-viniferin

1/2010alpha-Viniferin suppresses the signal transducer and activation of transcription-1 (STAT-1)-inducible inflammatory genes in interferon-gamma-stimulated macrophages.
8/2003Anti-inflammatory effect of the oligomeric stilbene alpha-Viniferin and its mode of the action through inhibition of cyclooxygenase-2 and inducible nitric oxide synthase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eun Yong Chung Research Topics

Disease

5Neoplasms (Cancer)
02/2022 - 10/2011
4Edema (Dropsy)
01/2010 - 05/2003
3Neoplasm Metastasis (Metastasis)
02/2022 - 02/2013
3Breast Neoplasms (Breast Cancer)
11/2013 - 02/2013
2Hemorrhage
02/2011 - 08/2010
1Colonic Neoplasms (Colon Cancer)
02/2022
1Cardiotoxicity
04/2021
1Allergic Rhinitis
08/2018
1Hyperalgesia
06/2015
1Carcinoma (Carcinomatosis)
11/2013
1Inflammation (Inflammations)
10/2011
1Cavernous Hemangioma (Cavernous Angioma)
02/2011
1Cranial Nerve Diseases (Cranial Nerve Disorders)
08/2010
1Hematoma
08/2010
1Subdural Hematoma (Subdural Hemorrhage)
08/2010
1Uveitis
08/2010
1Scleritis (Episcleritis)
08/2010
1Venous Thrombosis (Deep-Vein Thrombosis)
08/2010
1Spinal Epidural Hematoma
08/2010
1Hypoxia (Hypoxemia)
07/2010
1Arthritis (Polyarthritis)
01/2010
1Epistaxis (Nosebleed)
06/2009
1Factor XI Deficiency (Hemophilia C)
06/2009
1Immune System Diseases (Immune Disorders)
08/2008

Drug/Important Bio-Agent (IBA)

4CarrageenanIBA
01/2010 - 05/2003
3Matrix Metalloproteinase 9 (Gelatinase B)IBA
11/2013 - 02/2013
3ResveratrolIBA
10/2011 - 08/2003
2Anesthetics (Anesthetic Agents)IBA
08/2018 - 06/2009
2Transcription Factor AP-1 (Transcription Factor AP 1)IBA
04/2013 - 02/2013
2alpha-viniferinIBA
01/2010 - 08/2003
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
02/2022
1Aurora KinasesIBA
02/2022
1Aurora Kinase AIBA
02/2022
1Protein Kinase CIBA
02/2022
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
04/2021
1CannabinoidsIBA
04/2021
1Saline SolutionIBA
06/2015
1Vincristine (Oncovin)FDA LinkGeneric
06/2015
1Thioctic Acid (Lipoic Acid)IBA
06/2015
1Protein Tyrosine PhosphatasesIBA
11/2013
1Matrix Metalloproteinases (MMPs)IBA
11/2013
1sulforaphaneIBA
04/2013
1pregna-4,17-diene-3,16-dione (guggulsterone)IBA
02/2013
1Transcription Factors (Transcription Factor)IBA
02/2013
1Enoxaparin (Lovenox)FDA LinkGeneric
08/2010
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
08/2010
1enoxaparin sodiumFDA LinkGeneric
08/2010
1DNA (Deoxyribonucleic Acid)IBA
07/2010
1Small Interfering RNA (siRNA)IBA
07/2010
1Factor XI (Plasma Thromboplastin Antecedent)IBA
06/2009
1NF-kappa B (NF-kB)IBA
08/2008
12- methyl- 2- (2- methylpropenyl)- 2,3- dihydronaphtho(2,3- b)furan- 4,9- dioneIBA
10/2005
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
08/2003
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
08/2003
1sophoricosideIBA
05/2003
1Dihydrotachysterol (AT 10)IBA
05/2003

Therapy/Procedure

1Intraperitoneal Injections
06/2015
1Aftercare (After-Treatment)
06/2015
1Chemoprevention
10/2011
1Radiotherapy
02/2011
1Conservative Treatment
08/2010
1Anesthesia
08/2010
1Epidural Anesthesia
08/2010
1Hip Replacement Arthroplasty (Total Hip Replacement)
08/2010
1Knee Replacement Arthroplasty (Total Knee Replacement)
08/2010
1Perioperative Period
08/2010